Immunovant, Inc.

IMVT ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
UPLOAD Feb 18, 2021
CORRESP Feb 17, 2021
SC 13G/A Feb 16, 2021
8-K Feb 16, 2021 8-K
10-Q Feb 16, 2021 10-Q
UPLOAD Feb 2, 2021
8-K Feb 2, 2021 8-K
4 Jan 25, 2021 FORM 4
424B7 Jan 15, 2021 424B7
424B5 Jan 15, 2021 424B5
EFFECT Jan 14, 2021
3 Jan 14, 2021 FORM 3
CORRESP Jan 12, 2021
UPLOAD Jan 11, 2021
S-3 Jan 4, 2021 S-3
424B3 Nov 12, 2020 424B3
10-Q Nov 12, 2020 10-Q
8-K Nov 12, 2020 8-K
4 Sep 18, 2020 4
SC 13D/A Sep 18, 2020 SC 13D/A
8-K Sep 18, 2020 8-K
4 Sep 15, 2020 FORM 4
4 Sep 4, 2020 4
SC 13D/A Sep 4, 2020 SC 13D/A
4 Sep 4, 2020 FORM 4
← Newer Page 19 of 26 · 646 filings Older →